I don't have all of the resumes of the BOD at my f
Post# of 148331
CYDY is not built to run trials. If they DEVELOP trials that another company likes, then either partnership or acquisition are most likely and after a point, it becomes cheaper for a company to just acquire CYDY because that company would really be the one doing the heavy lifting.
Again, we all spoke about this a few months back for quite a while. It is not my idea and it is not a new idea.